Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial

Autor: Pettus, Jeremy, Boeder, Schafer C., Christiansen, Mark P., Denham, Douglas S., Bailey, Timothy S., Akturk, Halis K., Klaff, Leslie J., Rosenstock, Julio, Cheng, Mickie H. M., Bode, Bruce W., Bautista, Edgar D., Xu, Ren, Yan, Hai, Thai, Dung, Garg, Satish K., Klein, Samuel
Zdroj: Nature Medicine; November 2023, Vol. 29 Issue: 11 p2959-2959, 1p
Databáze: Supplemental Index
Externí odkaz: